Portfolio

The Wyvern Seed Fund has a mixed portfolio of investments across the two Universities. In addition to investments into new spin-out companies the Fund has been used to support the development and commercialisation of academic research and Intellectual Property, for example by establishing License Agreements or other collaborative ways of returning value from the science/technology.

Apitope |

Apitope

Apitope Technology is a biopharmaceutical company developing treatments for allergy and autoimmune diseases.

 www.apitope.com


Azellon |

Azellon

Azellon is developing a cellular therapy to repair knee mensicus cartilage.

 

www.azellonctx.com 


Binx Health |

Binx Health

Binx Health is developing rapid tests for serious disease such as chlamydia and the hospital superbug MRSA.

 

www.mybinxhealth.com


Boxarr |

Boxarr

Boxarr is commercialising a planning software tool for large complex product development projects.

 

www.boxarr.com


Graphcore |

Graphcore

Graphcore is a fabless semiconductor company spun out from Xmos that designs processors for servers

 www.graphcore.ai


Imetrum |

Imetrum

Imetrum has developed a high accuracy, non-contact measurement system for materials and structural testing and monitoring.

 

www.imetrum.com


Karus Therapeutics Ltd |

Karus Therapeutics Ltd

Karus Therapeutics is a biotechnology company developing innovative therapies to treat cancer, inflammation and heart disease.

 

www.karustherapeutics.com


Micrima |

Micrima

Micrima is developing a microwave array for high resolution breast tumour imaging.

 

 

www.micrima.com


Perpetuum Ltd |

Perpetuum Ltd

Perpetuum has developed a kinetic energy harvesting system which produces electrical energy for a variety of possible applications.

www.perpetuum.co.uk


Symetrica |

Symetrica

Symetrica is commercialising proprietary, high performance gamma-ray spectroscopy for detection of nuclear threat materials.

 www.symetrica.com


Vitamica Ltd |

Vitamica Ltd

Vitamica is developing a rapid method for testing whether bacterial pathogens in clinical samples are resistant or susceptible to antibiotics.

www.vitamica.co.uk


Xmos Ltd |

Xmos Ltd

Xmos is a semiconductor company with novel processor architecture that emulates hardware functionality.

 

www.xmos.com


Latest News
Binx Health receives FDA approval for diagnostic…
University of Bristol and University of Southampton